William Atkins
Analyst · Raymond James. Please state your question
Thank you, Carl. We last provided you with guidance regarding Q3 on the 28th of July. And in that guidance we estimated revenues of between $107 million and $111 million, a gross margin of between 49% and 50% and operating expenses in the range of $50 million to $51 million thus resulting in an EPS of between $0.05 and $0.09 per share. Actual revenue for the quarter was $112.3 million and EPS was $0.16 per share with revenues above the top end of our guidance and earnings per share also above guidance. We incurred some expenses in relation to our Occam litigation, and EPS would therefore have been slightly better at $0.17 per share if we exclude these litigation expenses. Driven by product and customer mix, gross margins came in at 49.3% and compared favourably to Q3, 2014 level of 44.8%. We continue to be pleased with the continuing growth in our gross margins. With 2015 year-to-date gross margins of 49.8% being above last year’s year-to-date gross margins of 46.1%. We remained focused on growing gross margins over time, but we also reiterate our view that there are likely to be fluctuations in those margins from quarter to quarter. Operating expenses came in at $47.2 million, below the bottom end of our $50 million to $51 million guidance range and up $4.5 million from the same quarter a year ago, with this year-over-year increase primarily due to additions in the headcount particularly in research and development. We recorded $0.6 million of Occam litigation related expenses in the quarter with operating expenses therefore being $46.6 million without taking into account these costs. A slower than anticipated pace of hiring contributed to our undershooting OpEx guidance. We do not break out cost that relates to turnkey network improvement projects, but I also note that we do defer cost directly attributable to these projects and that these will be reflected in our gross margins rather than in our operating expenses as we close out those projects and recognize the related revenues and the associated cost of revenues. We ended the quarter with a total of $93.9 million in cash and marketable securities, down from Q2’s $99.5 million figure. Q3 operating cash flow was in line with guidance at a positive $5.5 million. The primary driver of our overall use of cash in the quarter was our share repurchase program which amounted to $7.7 million of investments in our stock. We expect to continue to repurchase Calix shares under that share repurchase program, and we also expect neutral operating cash flow in Q4. Revenues for the quarter were $112.3 million, an increase of $6.5 million, or just over 6% higher than last year’s third quarter level of $105.8 million. International revenues were $14.4 million in Q3 up from $13.8 million in Q3, 2014. International revenues were 13% of Q3 total revenues and 11% of year-to-date total revenues. We had one 10% customer in the quarter. We have also seen increased demand from one other existing customer for the turnkey network improvement project that Carl and I noted earlier. With the revenue impact from those projects likely to be more heavily felt in 2016 we believe these projects will generate meaningful business and that this will also result in deferred revenues which will be recognized as they close out. Turning now to our balance sheet, receivables DSOs reminded at the same healthy 37 day level as in each of the first two quarters and were slightly better than the 39 days recorded for Q3, 2014. Inventory levels increased to $43.8 million in Q3 from Q2’s $40.7 million level and were in line with last years’ Q3 level of $43.8. Inventory turns increased to 4.6 times in Q3 from 4.0 times in Q2 and were equal to Q3 2014’s 4.6 times. During the remainder of the year you were likely to see an increase in inventory from its current levels as we continue to ramp up to meet the needs of turnkey network improvement projects. As expected and as per federal government guidelines all broadband stimulus projects were completed in Q3. I will now review how Calix performed over the first three quarters of 2015 relative to the same period last year. Year-to-date 2015 revenues increased by $12.9 million to $302.5 million or up 4.4% from last year’s $289.6 million level. And gross margins came in at 49.8% versus 2014’s number of 46.1%. Operating expenses increased by $17.6 million to $142.6 million for the first three quarters of 2015 versus 2014’s year-to-date level of $125 million. After deducting Occam litigation expenses of $2.4 million, the 2015 year-to-date operating expense figure would have increased by $15.2 million to $140.2 million figure up from an equivalent figure for last year of $125 million. Year-to-date 2015 earnings per share were $0.15 per share versus last year’s first nine months equivalent EPS of $0.16. Without the Occam litigation expense 2015 year-to-date EPS would have been $0.20. I’m now going to turn to our Q4 guidance and to its implications for the full 2015 year. Revenues for the fourth quarter are expected to be in a range of between $102 million and $106 million, with the resulting midpoint of $104 million being down 6% from the $111.6 million level achieved in Q4 of 2014. We are guiding to a 47% to 48% range for Q4 gross margins, broadly equivalent to last year’s Q4 level of 48.1%. 2015 Q4 gross margins will be impacted amongst other factors by customer and product mix and by our ability to close out some of the projects that we described earlier in this call. Operating expenses are expected to be in the range of $51.5 million to $52.5 million, up from last year’s Q4 level of $47.1 million. Occam litigation related expenses that will not be reimbursed by its insurers are expected to be approximately $1.5 million. Please note that a significant portion of the sequential increase versus Q3, 2015 $47.2 million is comprised of the usual one-off year end expenses that we incurred in Q4, including yearend sales commissions accelerator, the cost of our annual user group conference and an adjustment to reflect the alignment of our financial calendar with calendar year end. Over the past three years Q4 expenses have been 2% to 10% higher than in Q3, but these types of specific year end factors driving a lot of this increase. As evidenced by our announcements earlier this year, regarding G.fast and NG-PON2 and by our recent announcement of the new AXOS system architecture we continue to invest in incremental R&D resources to position ourselves to take advantage of the transformation that is underway in our sector and Carl will take you through our recent product launches later in this call. The expectation that I’ve just finished taking you through results in a guidance range for Q4 earnings per share of negative $0.07 to negative $0.03. If you were to exclude anticipated Occam litigation expenses EPS for Q4 would be negative $0.04 to $0.00 per share. Having issued guidance for Q4, I can therefore now share with you the implied outturn for the full 2015 year. For 2015, revenues will be in the $404.4 million to $408.4 million range, up from 2014 $401.2 million level. Gross margins should be in a 49.1% to 49.4% range, up from 2014’s 46.7%. And annual operating expenses are expected to be $194.1million to $195.1 million up from 2014’s $172.1 million level. At this point, I’m handing the call back over to Carl.